CompletedPhase 1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease

NCT03976349

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Northwestern University PD and Movement Disorders Center

Chicago, Illinois, United States

+17 additional locations

Save this trial

Northwestern University PD and Movement Disorders CenterChicago, Illinois, United States
Quest Research InstituteFarmington Hills, Michigan, United States
The Cleveland Clinic FoundationCleveland, Ohio, United States
Oregon Health and Science UniversityPortland, Oregon, United States
University of PennsylvaniaPhiladelphia, Pennsylvania, United States
Alliance for Multispecialty ResearchKnoxville, Tennessee, United States
Inland Northwest ResearchSpokane, Washington, United States
Research SiteToronto, Ontario, Canada
Montreal Neurological Institute and HospitalMontreal, Quebec, Canada
Sourasky Medical CenterTel Aviv, Israel
Neuro-SysMed CenterBergen, Norway
St. Olav University HospitalTrondheim, Norway
Laboratorios de Investigación Biocruces 3., Hospital de CrucesBarakaldo, Bizkaia, Spain
Hospital General de CatalunyaBarcelona, Vizcaya, Spain
Hospital Clinic de BarcelonaBarcelona, Spain
Hospital General Universitario Gregorio MarañónMadrid, Spain
Research SiteSeville, Spain
Queen Square (Neurology) CRF Site Institute of Neurology & the National Hospital for Neurology and Neurosurgery UCLHLondon, United Kingdom